Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.52), $0.13 better than the analyst estimate of ($1.65).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.